➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKinsey
Dow
Colorcon
AstraZeneca

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Align Technology, Inc. v. 3Shape A/S (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Align Technology, Inc. v. 3Shape A/S (D. Del. 2018)

Docket   Start Trial Date Filed 2018-12-11
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Patents 10,004,700; 10,004,807; 10,004,819; 10,023,894; 10,028,912; 10,039,810; 10,052,337; 10,064,856; 10,064,875; 10,071,136; 10,071,157; 10,071,284; 10,082,510; 10,086,047; 10,086,080; 10,099,430; 10,105,374; 10,107,819; 10,111,830; 10,117,844; 10,117,881; 10,117,886; 10,118,881; 10,119,905; 10,123,975; 10,124,024; 10,124,064; 10,144,881; 10,284,108; 10,337,003; 10,337,018; 10,337,070; 10,374,072; 10,380,700; 10,387,930; 10,507,111; 6,059,675; 6,071,510; 6,074,374; 6,087,129; 6,087,380; 6,150,091; 6,302,897; 6,337,097; 6,420,110; 6,894,050; 6,899,897; 6,905,886; 6,930,093; 6,930,106; 6,930,119; 6,930,127; 7,026,374; 7,041,302; 7,049,285; 7,056,886; 7,060,675; 7,060,875; 7,067,551; 7,090,830; 7,101,882; 7,125,875; 7,125,905; 7,128,894; 7,202,057; 7,294,073; 7,294,074; 7,374,551; 7,375,100; 7,375,111; 7,420,057; 7,420,069; 7,507,284; 7,510,551; 7,700,081; 7,700,118; 7,700,127; 7,700,128; 7,700,144; 7,700,284; 7,807,135; 7,897,050; 8,003,819; 8,019,551; 8,021,875; 8,026,284; 8,034,809; 8,048,118; 8,062,897; 8,067,551; 8,071,294; 8,080,551; 8,088,150; 8,093,045; 8,105,380; 8,114,380; 8,119,123; 8,119,129; 8,124,055; 8,124,094; 8,129,034; 8,129,114; 8,129,507; 8,202,099; 8,202,897; 8,294,007; 8,298,102; 8,410,082; 8,410,086; 8,410,136; 8,420,054; 8,420,056; 8,420,081; 8,420,086; 8,420,089; 8,420,106; 8,551,091; 8,809,005; 8,809,006; 8,809,010; 8,809,059; 8,809,507; 8,882,298; 8,897,076; 8,912,122; 8,975,034; 8,975,055; 9,006,387; 9,011,905; 9,023,807; 9,034,374; 9,045,809; 9,050,302; 9,062,106; 9,062,121; 9,062,294; 9,066,856; 9,066,930; 9,067,083; 9,075,057; 9,078,881; 9,079,905; 9,079,912; 9,090,700; 9,101,810; 9,107,886; 9,107,912; 9,108,975; 9,114,069; 9,114,284; 9,119,810; 9,125,905; 9,125,930; 9,126,082; 9,127,069; 9,150,881; 9,157,061; 9,157,084; 9,284,380; 9,302,002; 9,375,013; 9,375,126; 9,387,094; 9,551,009; 9,551,033; 9,675,082; 9,675,675; 9,675,700; 9,700,050; 9,844,510; 9,856,065; 9,856,510; 9,975,021; 9,975,894
Link to Docket External link to docket

Details for Align Technology, Inc. v. 3Shape A/S (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-18 72 Complaint - Amended 2019, the U.S. Patent and Trademark Office duly and lawfully issued U.S. Patent No. 10,507,088 (“the …duly and lawfully issued U.S. Patent No. 10,507,089 (“the ’089 patent”), entitled “Imaging Apparatus …of the ’430 patent, including the TRIOS 3 and 4 scanners. 58. The ’430 patent is generally…and 4 scanners infringe at least claim 1 of the ’430 patent. For example, 3Shape’s TRIOS 3 and 4 scanners…of the ’088 patent, including the TRIOS 3 and 4 scanners. 96. The ’088 patent is generally External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
McKesson
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.